Is dabrafenib included in medical insurance?

Dabrafenib is a kinase inhibitor indicated as a single agent for the treatment of patients with unresectable or metastatic melanoma in whom the BRAF V600E mutation is detected in an FDAapproved test. The combination of dabrafenib and trametinib is used in patients with non-small cell lung cancer, which is shown to have the "BRAF V600E" gene.

Dabrafenib was approved by the national food and drug administration department to be officially launched in my country on December 12, 2019. The price in domestic pharmacies is more than 9,000 yuan for 75 mg 120 tablets. The price in Turkish pharmacies is about 11,000 yuan for 75 mg 120 tablets. If patients consider the economy, they can choose generic drugs that are officially marketed overseas. This drug is produced by Laos Daxiong Pharmaceutical and has been marketed with government approval. The retail price of 75 mg 120 tablets in Laos is more than 1,000. The retail price of trametinib and dabrafenib is more than 4 thousand per set. Patients can choose drug versions based on their financial situation.

Dabrafenib + Trametinib targets BRAF+ the underlying cause of cancer. Inhibiting MEK1 and MEK2 can inhibit downstream signaling in the MAPK pathway. Inhibiting downstream signaling reduces ERK-driven gene expression and cell proliferation, invasion, and survival. The recommended daily dose of dabrafenib is150 mg twice daily. Be sure to take it 12 hours apart. If you want to get more high-quality information, you can contact Yaode , Yaode will do its best to learn more about high-quality overseas drugs for you.